Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 3 | 2009 | 690 | 0.530 |
Why?
|
| Barrett Esophagus | 5 | 2014 | 569 | 0.380 |
Why?
|
| Breast Neoplasms, Male | 1 | 2009 | 229 | 0.310 |
Why?
|
| Felty Syndrome | 1 | 2023 | 3 | 0.240 |
Why?
|
| Hand Dermatoses | 1 | 2023 | 25 | 0.240 |
Why?
|
| Bacterial Infections | 1 | 2008 | 479 | 0.240 |
Why?
|
| Sweet Syndrome | 1 | 2023 | 36 | 0.230 |
Why?
|
| Dermatitis | 1 | 2023 | 60 | 0.230 |
Why?
|
| Gastritis | 2 | 2017 | 373 | 0.200 |
Why?
|
| Skin Diseases | 1 | 2023 | 349 | 0.190 |
Why?
|
| Neutropenia | 1 | 2023 | 968 | 0.170 |
Why?
|
| Carcinoma | 1 | 2009 | 2578 | 0.150 |
Why?
|
| Waist-Hip Ratio | 2 | 2013 | 59 | 0.140 |
Why?
|
| Diet | 2 | 2013 | 1440 | 0.130 |
Why?
|
| Helicobacter Infections | 3 | 2014 | 1216 | 0.130 |
Why?
|
| Glycation End Products, Advanced | 1 | 2013 | 31 | 0.120 |
Why?
|
| Helicobacter pylori | 2 | 2014 | 1295 | 0.110 |
Why?
|
| Meat | 1 | 2013 | 87 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2015 | 176 | 0.110 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2013 | 73 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 4 | 2014 | 202 | 0.100 |
Why?
|
| Breast | 2 | 2009 | 1344 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 198 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2013 | 262 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2013 | 241 | 0.100 |
Why?
|
| Eosinophilia | 1 | 2013 | 176 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 550 | 0.090 |
Why?
|
| Vegetables | 1 | 2013 | 325 | 0.090 |
Why?
|
| Adenocarcinoma | 4 | 2011 | 7789 | 0.090 |
Why?
|
| Folic Acid | 1 | 2013 | 349 | 0.090 |
Why?
|
| Colorectal Neoplasms | 3 | 2011 | 3578 | 0.090 |
Why?
|
| Antioxidants | 1 | 2013 | 507 | 0.090 |
Why?
|
| Logistic Models | 5 | 2014 | 3441 | 0.090 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 159 | 0.080 |
Why?
|
| Psoas Muscles | 1 | 2008 | 12 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 610 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2011 | 238 | 0.080 |
Why?
|
| Myocardium | 1 | 2015 | 1313 | 0.080 |
Why?
|
| Mycobacterium Infections | 1 | 2008 | 49 | 0.080 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 109 | 0.080 |
Why?
|
| Aged | 15 | 2017 | 70117 | 0.080 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 55 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2014 | 6100 | 0.070 |
Why?
|
| Adenoma, Villous | 1 | 2006 | 10 | 0.070 |
Why?
|
| Biopsy | 2 | 2012 | 3443 | 0.070 |
Why?
|
| Middle Aged | 12 | 2023 | 86204 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2012 | 2203 | 0.060 |
Why?
|
| Male | 16 | 2023 | 123000 | 0.060 |
Why?
|
| Risk Factors | 7 | 2017 | 17523 | 0.060 |
Why?
|
| Mycoses | 1 | 2008 | 386 | 0.060 |
Why?
|
| Hyperthyroidism | 1 | 2004 | 52 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 4314 | 0.060 |
Why?
|
| Blister | 1 | 2023 | 31 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2013 | 2316 | 0.060 |
Why?
|
| Filgrastim | 1 | 2023 | 191 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 29902 | 0.060 |
Why?
|
| Hernia, Hiatal | 2 | 2013 | 63 | 0.060 |
Why?
|
| Prevalence | 3 | 2017 | 3260 | 0.050 |
Why?
|
| Carcinoma, Medullary | 1 | 2004 | 248 | 0.050 |
Why?
|
| Anus Neoplasms | 1 | 2006 | 411 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2007 | 1271 | 0.050 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 4971 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 2173 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2008 | 5637 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2007 | 2022 | 0.040 |
Why?
|
| Adult | 7 | 2017 | 77950 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 3151 | 0.040 |
Why?
|
| Female | 11 | 2017 | 141928 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 4298 | 0.030 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2015 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 136 | 0.030 |
Why?
|
| Etidronic Acid | 1 | 2013 | 10 | 0.030 |
Why?
|
| Alendronate | 1 | 2013 | 18 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 7551 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 2013 | 123 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 598 | 0.030 |
Why?
|
| Texas | 2 | 2013 | 6311 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2015 | 351 | 0.030 |
Why?
|
| Lysine | 1 | 2013 | 422 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 402 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2013 | 249 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1363 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 334 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 5687 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 687 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2014 | 518 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 760 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 1182 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2015 | 1145 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 613 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 10001 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 14289 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 275 | 0.020 |
Why?
|
| Spleen | 1 | 2007 | 676 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 37905 | 0.020 |
Why?
|
| Anal Canal | 1 | 2006 | 238 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 589 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2009 | 2231 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 14551 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 7548 | 0.010 |
Why?
|
| Colon | 1 | 2007 | 670 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 1301 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 660 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 2314 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 1226 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 21713 | 0.010 |
Why?
|
| Veterans | 1 | 2013 | 1641 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2009 | 1824 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 4844 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 984 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 3890 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3981 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 1270 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2884 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 4307 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 6682 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6207 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 3168 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 3821 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 12873 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8865 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2359 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 2967 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 4975 | 0.010 |
Why?
|
| United States | 1 | 2013 | 15433 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 32848 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 7222 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 13658 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 34495 | 0.000 |
Why?
|
| Animals | 1 | 2007 | 59536 | 0.000 |
Why?
|